RUNX1T1 and neoplasm: Mice with wild-type Runx1t1 (Runx1t1+/+) had 92% tumor incidence (93/101), as expected on this background, while Runx1t1 haploinsufficiency decreased tumor incidence to 6.5% (10/163).